Certepetide
- Generic Name
- Certepetide
A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma
Phase 2
Not yet recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Interventions
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT06261359
- Locations
- 🇨🇳
Chinese People's Liberation Army (PLA) General Hospital, Beijing, Beijing, China
CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab
Phase 1
Active, not recruiting
- Conditions
- Digestive CancerColon CancerPancreas Cancer
- Interventions
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Anup Kasi
- Target Recruit Count
- 50
- Registration Number
- NCT05121038
- Locations
- 🇺🇸
The University of Kansas Cancer Center (KUCC), Fairway, Kansas, United States
🇺🇸The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas, United States
🇺🇸The University of Kansas Medical Center, North Kansas City, Missouri, United States
CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
- First Posted Date
- 2021-09-22
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT05052567
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic CancerPancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2018-05-07
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Lisata Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03517176
- Locations
- 🇦🇺
Alfred Hospital, Melbourne, Victoria, Australia
🇦🇺Queen Elizabeth Hospital, Woodville South, South Australia, Australia
🇦🇺St John of God Hospital, Subiaco, Western Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath